Dermatology research Trials

We currently run two registry studies, as follows.

BADBIR

British Association of Dermatologists Biological Interventions Register

Principal Investigators: May Havinden-Williams and Dr Antonia Lloyd-Lavery

BADBIR stands for the British Association of Dermatologists Biologic and Immunomodulators Register.

We are a UK and Eire observational study seeking to assess the long-term safety of biologic treatments for psoriasis. The National Institute for Health and Clinical Excellence (NICE) has recommended that all patients in the UK receiving these new therapies for psoriasis should be registered with us. Once a patient has joined BADBIR, they are followed up via their dermatologist as we assess their clinical details.

There are currently over 160 hospital sites across the UK and Eire taking part in BADBIR by recruiting participants to join the Register. We have over 18,000 registrations in the study, with more than 110,000 follow-ups entered.

The website is:

British Association of Dermatologists Biologic Interventions Register

BADBIR is based at the University of Manchester and is part of the Arthritis Research UK Epidemiology Unit.

A-STAR

The UK-Irish Atopic eczema Systemic TherApy Register

Principal Investigator: Joanna Searle

A-STAR stands for The UK-Irish Atopic Eczema Systemic Therapy Register.

We are an observational study running in the UK and Ireland, seeking to assess the short and long-term safety and efficacy of systemic immuno-modulators for people of all ages with atopic eczema.

We will also look at the 'real life' cost of treating eczema, examining how much these therapies cost compared to how well they work.

Once patients sign up to participate in A-STAR, we will follow their medical care via their local dermatologists.

The overall aim is to help clinicians in their treatment decisions of patients with atopic eczema and through this to improve patient care.

A-STAR is based at the St John's Institute of Dermatology at St Thomas' Hospital London.

Other studies

We also run a variety of other clinical trials, including both observational trials and clinical trials of investigational medicinal products (CTIMPs).

Currently we run trials for conditions such as:

• Alopecia Areata
  
• Eczema
  
• Psoriasis
  
• Lichen Sclerosis (LS)
  
• Chronic Spontaneous Urticaria (CSU)
  
• Chronic Inducible Urticaria (CINDU)
  
• Skin Cancer and Surgical Dermatology